MedTrace Logo

First Clinical Live-Donor Uterus Transplantation Trial In Egypt

NCT03284073 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2021-03-30

No results posted yet for this study

Summary

More than a decade ago, uterus transplantation (UTx) as a highly experimental procedure was the treatment which had been developed for women suffering from absolute uterine factor infertility (AUFI) \[uterus absence (congenital and surgical), or an abnormality (anatomic and functional)\].

In Egypt, People's religions, current ethical and legal backgrounds make the option of live-donor uterus transplantation appealing rather than alternative pathways to parenthood. Thus, its clinical application for the first time in Egypt should be initiated after an extensive review and analysis of literature for UTx technology development in the world, and for further possible contributions to future prospects by Egypt proposed UTx project team which will participate in our study.

Conditions

  • Primary Uterine Infertility

Interventions

PROCEDURE

Uterus transplantation

Transplantation of the uterus from a live donor and IVF treatment

Sponsors & Collaborators

  • Al-Azhar University

    collaborator OTHER

  • Mansoura University

    collaborator OTHER

  • Amro M. Hetta, M.Sc.

    lead OTHER_GOV

Principal Investigators

  • Amro M. Hetta, M.Sc. · Al-Azhar University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-09-30
Completion
2022-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284073 on ClinicalTrials.gov